Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Quotient Sciences - Philadelphia, LLC
483
•Quotient Sciences - Philadelphia, LLC•September 17, 2025

Quotient Sciences - Philadelphia, LLC – FDA 483, Sep 17, 2025

Record Details

Quotient Sciences - Philadelphia, LLC received an FDA Form 483 following an inspection conducted from September 8 to September 17, 2025. The observations highlight significant concerns regarding manufacturing controls and adherence to Good Manufacturing Practices (GMP) for drug products.

Key issues included a failure to follow written procedures for equipment cleaning and maintenance. Investigators observed white residue on equipment designated as clean, which is used for potent and investigational drug products. The firm’s cleaning validation protocol for this equipment was not properly executed, specifically regarding visual inspection techniques.

Furthermore, the company did not adequately prevent contamination through its cleaning processes. The firm’s risk assessment for cleaning validation lacked scientific justification for swab locations and consistent sampling site descriptions, a deficiency noted as a repeat observation from a 2022 inspection.

Personnel practices also posed contamination risks. Inspectors documented instances of operators removing beard covers and unzipping protective suits to use cell phones within processing rooms, directly violating the firm’s established gowning procedures designed to protect drug products from contamination.

Under the Federal Food, Drug, and Cosmetic Act, Quotient Sciences is required to address these conditions to ensure drug products are not prepared or held under insanitary conditions. The firm must implement comprehensive corrective and preventive actions, including revising and enforcing cleaning validation protocols, strengthening equipment maintenance, and ensuring strict adherence to gowning procedures, to prevent recurrence and maintain product quality and safety.

Company
Quotient Sciences - Philadelphia, LLC
Inspection date
September 17, 2025
Product type
drugs
Office
Philadelphia District Office
People
  • Anastasia M. Shields (Consumer Safety Officer )
  • Ruben C. Quintana
View Company Profile

ID · 8d25ba6a-3e0e-4251-8141-69b0bca01e7d

Other documents for Quotient Sciences - Philadelphia, LLC
  • EIR - 2022-12-22December 22, 2022
  • 483 - 2022-12-22December 22, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Quotient Sciences - Philadelphia, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.